Cargando…
352 Computational methods for predicting drug combinations for targeting KRAS mutations relevant to non-small cell lung cancer
OBJECTIVES/GOALS: Our goal is to develop a cost-effective approach for precision medicine treatment by providing computational predictions for new uses of currently available FDA approved, and experimental drugs for NSCLC. METHODS/STUDY POPULATION: Cell Lines: A549 (ATCC- CCL-185) Human epithelial L...
Autores principales: | Bruggemann, Liana, Falls, Zackary, Mangione, William, Mahajan, Supriya, Samudrala, Ram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209286/ http://dx.doi.org/10.1017/cts.2022.200 |
Ejemplares similares
-
Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer
por: Bruggemann, Liana, et al.
Publicado: (2023) -
224 Ends of Endemics: Capturing Viral UTRs in Clinically Relevant Arbovirus Samples
por: Morris, Victoria, et al.
Publicado: (2022) -
371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction
por: Samudrala, Sai Suma, et al.
Publicado: (2022) -
467 Post-transcriptional regulation of the MiaA prenyl transferase by the small RNA CsrB in Escherichia coli (E. coli)
por: Aubee, Joseph I, et al.
Publicado: (2022) -
323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
por: Reed, Megan R., et al.
Publicado: (2022)